PT1149910E - Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus - Google Patents

Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus

Info

Publication number
PT1149910E
PT1149910E PT01109013T PT01109013T PT1149910E PT 1149910 E PT1149910 E PT 1149910E PT 01109013 T PT01109013 T PT 01109013T PT 01109013 T PT01109013 T PT 01109013T PT 1149910 E PT1149910 E PT 1149910E
Authority
PT
Portugal
Prior art keywords
infections
papilomavirus
pharmaceutical composition
composition against
against tumors
Prior art date
Application number
PT01109013T
Other languages
English (en)
Inventor
Nadine Bizouarne
Marie-Paule Kieny
Jean-Marc Balloul
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1149910(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PT1149910E publication Critical patent/PT1149910E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
PT01109013T 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus PT1149910E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609584A FR2751879B1 (fr) 1996-07-30 1996-07-30 Composition pharmaceutique contre les tumeurs et infections a papillomavirus

Publications (1)

Publication Number Publication Date
PT1149910E true PT1149910E (pt) 2004-09-30

Family

ID=9494633

Family Applications (2)

Application Number Title Priority Date Filing Date
PT01109013T PT1149910E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
PT97935646T PT862634E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e infeccoes de papilomavirus

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT97935646T PT862634E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e infeccoes de papilomavirus

Country Status (12)

Country Link
EP (2) EP1149910B1 (pt)
JP (2) JP4070815B2 (pt)
AT (2) ATE205881T1 (pt)
AU (1) AU736720B2 (pt)
CA (1) CA2234263C (pt)
DE (2) DE69706825T3 (pt)
DK (2) DK1149910T3 (pt)
ES (2) ES2163795T5 (pt)
FR (1) FR2751879B1 (pt)
HK (1) HK1043809B (pt)
PT (2) PT1149910E (pt)
WO (1) WO1998004705A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US20020039584A1 (en) 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
US6926897B1 (en) 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
CA2335506A1 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Mucosal targeting immunisation
DK2029756T3 (en) * 2006-06-20 2017-02-13 Transgene Sa PROCEDURE FOR PREPARING POXVIRA AND POXVIRUS COMPOSITIONS
PL2382474T3 (pl) 2009-01-20 2015-08-31 Transgene Sa Rozpuszczalny ICAM-1 jako biomarker do prognozowania odpowiedzi terapeutycznej
KR20110138354A (ko) 2009-03-24 2011-12-27 트랜스진 에스.에이. 환자를 모니터링하기 위한 바이오마커
SG175060A1 (en) 2009-04-17 2011-11-28 Transgene Sa Biomarker for monitoring patients
CA2760465A1 (en) 2009-05-12 2010-11-18 Transgene Sa Method for orthopoxvirus production and purification
HUE028240T2 (en) 2009-07-10 2016-12-28 Transgene Sa Biomarker Patient Selection and Related Procedures
EP2456461A1 (en) 2009-07-21 2012-05-30 Transgene SA Enzymatic composition for the digestion of chicken embryos
TWI690322B (zh) 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
DK3226894T3 (da) 2014-12-01 2019-10-21 Transgene Sa Stabile flydende vacciniavirus-formuleringer
FR3042121A1 (fr) * 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
US11306292B2 (en) 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
WO2018211419A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
AU2019336940A1 (en) 2018-09-06 2021-03-11 Bavarian Nordic A/S Storage improved poxvirus compositions
WO2021180943A1 (en) 2020-03-12 2021-09-16 Bavarian Nordic A/S Compositions improving poxvirus stability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2643817B1 (fr) * 1989-03-06 1993-12-17 Transgene Sa Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
IE910909A1 (en) † 1990-03-20 1991-09-25 Behringwerke Ag Seroreactive epitopes of human Papillomavirus (HPV) 16¹proteins
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
ATE332973T1 (de) * 1991-07-19 2006-08-15 Univ Queensland Polynukleotidabschnitt des hpv16-genoms
US5618536A (en) * 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
IL113817A (en) * 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide for vaccination against the umbilical cord virus
AU712714B2 (en) * 1994-10-03 1999-11-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule B7 gene in a recombinant virus expressing system
GB9505784D0 (en) * 1995-03-22 1995-05-10 Lynxvale Ltd Anti-tumour treatment
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique

Also Published As

Publication number Publication date
DK0862634T3 (da) 2002-01-21
FR2751879A1 (fr) 1998-02-06
HK1043809A1 (en) 2002-09-27
ES2163795T5 (es) 2006-07-16
HK1043809B (zh) 2004-12-03
WO1998004705A1 (fr) 1998-02-05
JP2000500662A (ja) 2000-01-25
EP1149910A1 (fr) 2001-10-31
ATE265535T1 (de) 2004-05-15
ES2163795T3 (es) 2002-02-01
EP1149910B1 (fr) 2004-04-28
JP4198735B2 (ja) 2008-12-17
AU736720B2 (en) 2001-08-02
ES2215805T3 (es) 2004-10-16
CA2234263C (fr) 2009-10-13
DE69728914D1 (de) 2004-06-03
JP4070815B2 (ja) 2008-04-02
AU3855297A (en) 1998-02-20
DK1149910T3 (da) 2004-08-02
CA2234263A1 (fr) 1998-02-05
FR2751879B1 (fr) 1998-10-30
DE69706825T3 (de) 2006-08-24
JP2007254474A (ja) 2007-10-04
DE69706825T2 (de) 2002-05-02
DE69728914T2 (de) 2005-04-07
EP0862634B2 (fr) 2006-03-01
EP0862634B1 (fr) 2001-09-19
DK0862634T4 (da) 2006-05-08
EP0862634A1 (fr) 1998-09-09
ATE205881T1 (de) 2001-10-15
PT862634E (pt) 2002-03-28
DE69706825D1 (de) 2001-10-25

Similar Documents

Publication Publication Date Title
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
ATE525387T1 (de) Rekombinante p53 x adenovirus-konstrukte methoden und zusammensetzungen
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
AU589939B2 (en) Medical composition for injection containing a spergualin as active ingredient and process for preparing the same
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
UA50808C2 (uk) Композиція для лікування респіраторного дистрес-синдрому дорослих або респіраторного дистрес-синдрому новонароджених
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
IL102038A0 (en) Substituted diaminophthalimides and analogues
ATE92542T1 (de) Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor|than.
EP0127124A3 (en) Compounds for treating hypertension
MY101169A (en) Novel phenylureas
DE69619530T2 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
AU6722498A (en) Disubstituted biphenyloxazolines
KR970702880A (ko) 신규한 펩티드 활성 물질 및 그의 제조 방법(New Peptide Active Substance And Production Thereof)
EP0153755A3 (en) Compounds for treating hypertension
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante
IT8921095A0 (it) Composizione per l'aumento del guadagno di peso.
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ